SCHEMBL2327433

SCHEMBL2327433

CCCOC(=O)[C@H](CCSC)NC(=O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.60
KMT2A Q03164 2/20 0.57
ALDH1A1 P00352 2/20 0.57
MEN1 O00255 1/20 0.57
CRHBP P24387 1/20 0.57
CRHR2 Q13324 1/20 0.57
NPC1 O15118 1/20 0.51
CA2 P00918 3/20 0.50
CA1 P00915 2/20 0.50
CA12 O43570 2/20 0.50
CA9 Q16790 2/20 0.50
CYP26A1 O43174 1/20 0.50
TAS1R3 Q7RTX0 1/20 0.50
TAS1R1 Q7RTX1 1/20 0.50
LMNA P02545 2/20 0.48
TSHR P16473 1/20 0.48
CCR1 P32246 1/20 0.47
USP2 O75604 1/20 0.46
TP53 P04637 1/20 0.46
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27974764 1.00 L3MBTL1 (0.60) L3MBTL1KMT2AALDH1A1MEN1CRHBP
SCHEMBL2330865 0.90 L3MBTL1 (0.63) L3MBTL1KMT2AALDH1A1MEN1CRHBP
SCHEMBL27974663 0.90 L3MBTL1 (0.63) L3MBTL1KMT2AALDH1A1MEN1CRHBP
SCHEMBL18095164 0.87 L3MBTL1 (0.74) L3MBTL1KMT2AALDH1A1MEN1CRHBP
SCHEMBL2323686 0.87 L3MBTL1 (0.74) L3MBTL1KMT2AALDH1A1MEN1CRHBP
SCHEMBL2327912 0.84 FNTA (0.52) L3MBTL1KMT2A
SCHEMBL2327909 0.84 FNTA (0.52) L3MBTL1KMT2A
SCHEMBL2334148 0.82 POLB (0.52) L3MBTL1TSHR
SCHEMBL2334144 0.82 POLB (0.52) L3MBTL1TSHR
SCHEMBL1158031 0.82 CA2 (0.69) KMT2AALDH1A1MEN1CRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356979-B1 ANTI-WRINKLE AGENTS POLA CHEM IND INC (JP) 2017-10-25 EP disclosed
EP-3173063-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2017-05-31 EP disclosed
US-8835498-B2 Anti-wrinkle agents POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-16 US disclosed
CN-102215812-B Anti-wrinkle agents POLA CHEM IND INC 2014-09-10 CN disclosed
US-20110245343-A1 ANTI-WRINKLE AGENTS POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
EP-2356979-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2011-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245343-A1 ANTI-WRINKLE AGENTS GLA, H1-4, H1-3 L3MBTL1 1901/4885KMT2A 3153/4885ALDH1A1 2655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.